Quantification of Edema Reduction Using Differential Quantitative T2 (DQT2) Relaxometry Mapping in Recurrent Glioblastoma Treated With Bevacizumab

Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-011-0638-x

Related search